Information  X 
Enter a valid email address

Polar Capital Hldgs (POLR)

  Print      Mail a friend       Annual reports

Monday 03 February, 2020

Polar Capital Hldgs

Block listing Interim Review

RNS Number : 7554B
Polar Capital Holdings PLC
03 February 2020
 

POLAR CAPITAL HOLDINGS PLC

Legal Entity Identifier: 549300OXX7YE1947B825

BLOCK LISTING RETURN - 3 February 2020

Name of applicant:

Polar Capital Holdings plc

Name of scheme:

Equity Incentive Plan

Executive Incentive Plan

SAYE Sharesave Scheme

Preference Share Crystallisation

Period of return:

From:

1 August 2019

To:

31 January 2020

Balance of unallotted securities under scheme(s) from previous return:

Equity Incentive Plan -                       1,111,871

Executive Incentive Plan -                 1,000,000

SAYE Sharesave Scheme -                    416,693

Preference Share Crystallisation -   2,436,032

 

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Equity Incentive Plan -                       NIL

Executive Incentive Plan -                 NIL

SAYE Sharesave Scheme -                 NIL

Preference Share Crystallisation -   1,442,500

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Equity Incentive Plan -                      NIL

Executive Incentive Plan -                NIL

SAYE Sharesave Scheme -                NIL

Preference Share Crystallisation -      144,206

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

Equity Incentive Plan -                       1,111,871

Executive Incentive Plan -                 1,000,000

SAYE Sharesave Scheme -                    416,693

Preference Share Crystallisation -   3,734,326

 

 

Name of contact:

Neil Taylor

Telephone number of contact:

020 7227 2700

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BLRMZGGZMFMGGZM

a d v e r t i s e m e n t